Percutaneous VA-ECMO from Cannulation to Decannulation: Novel Use of a Vascular Closure Device in Pediatrics.


Journal

Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 04 04 2023
accepted: 26 06 2023
medline: 18 8 2023
pubmed: 7 7 2023
entrez: 7 7 2023
Statut: ppublish

Résumé

VA-ECMO can be lifesaving in cardiogenic shock in children. While surgical vascular repair is the current standard of care for decannulation, it comes with notable risks. We present a series of eight patients who underwent decannulation with a collagen plug-based vascular closure device (MANTA) for the common femoral artery. Seven of the patients were successfully decannulated without access site-related vascular complications. One required conversion to surgical cut-down with arterial repair due to device failure. This series demonstrates the successful use of the MANTA device in percutaneous VA-ECMO decannulation in the pediatric population, while highlighting potential technical challenges for success.

Identifiants

pubmed: 37418147
doi: 10.1007/s00246-023-03222-w
pii: 10.1007/s00246-023-03222-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1623-1628

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Halim J, Missault L, Lycke M et al (2020) Assessment of the MANTA closure device in transfemoral transcatheter aortic valve replacement: a single-centre observational study. Neth Heart J 28(12):639–644
doi: 10.1007/s12471-020-01465-3 pubmed: 32720122 pmcid: 7683762
Majunke N, Mangner N, Linke A et al (2016) Comparison of percutaneous closure versus surgical femoral cutdown for decannulation of large-sized arterial and venous access sites in adults after successful weaning of veno-arterial extracorporeal membrane oxygenation. J Invasive Cardiol 28(10):415–419
pubmed: 27705891
Góreczny S, McLennan D, Morgan GJ (2019) Accessing extracorporeal membrane oxygenation circuits to perform emergent interventional cardiac catheterisation. Cardiol Young 29(10):1290–1293
doi: 10.1017/S1047951119001446 pubmed: 31511102
Hassan MF, Lawrence M, Lee D et al (2020) Simplified percutaneous VA ECMO decannulation using the MANTA vascular closure device: Initial US experience. J Card Surg 35(1):217–221
doi: 10.1111/jocs.14308 pubmed: 31899831
Montero-Cabezas JM, van der Meer RW, van der Kley F et al (2019) Percutaneous decannulation of femoral venoarterial ECMO cannulas using MANTA vascular closure device. Can J Cardiol 35(6):796.e9-796.e11
doi: 10.1016/j.cjca.2019.02.010 pubmed: 31151721
Moccetti F, Brinkert M, Seelos R et al (2019) Insights from a multidisciplinary introduction of the MANTA vascular closure device. JACC Cardiovasc Interv 12(17):1730–1736
doi: 10.1016/j.jcin.2019.06.049 pubmed: 31488301
Van Mieghem NM, Latib A, van der Heyden J et al (2017) Percutaneous plug-based arteriotomy closure device for large-bore access: a multicenter prospective study. JACC Cardiovasc Interv 10(6):613–619
doi: 10.1016/j.jcin.2016.12.277 pubmed: 28335899
Nuis RJ, Wood D, Kroon H et al (2022) Frequency, impact, and predictors of access complications with plug-based large-bore arteriotomy closure - a patient-level meta-analysis. Cardiovasc Revasc Med 34:69–74
doi: 10.1016/j.carrev.2021.02.017 pubmed: 33612412
Wood DA, Krajcer Z, Sathananthan J et al (2019) Pivotal clinical study to evaluate the safety and effectiveness of the MANTA percutaneous vascular closure device. Circ Cardiovasc Interv 12(7):e007258
doi: 10.1161/CIRCINTERVENTIONS.119.007258 pubmed: 31296082
Bemtgen X, Heidt T, Zotzmann V et al (2020) Venoarterial extracorporeal membrane oxygenation decannulation using the novel MANTA vascular closure device. Eur Heart J Acute Cardiovasc Care 9(4):342–347
doi: 10.1177/2048872620918707 pubmed: 32363881
Miyashita H, Moriyama N, Laine M (2022) Incidence and predictors of access site vascular complications following ultrasound-guided MANTA closure deployment. J Endovasc Ther 29(4):576–585
doi: 10.1177/15266028211059446 pubmed: 34852659
van Wiechen MP, Kroon H, Hokken TW et al (2021) Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: predictors and bail-outs. Catheter Cardiovasc Interv 98(5):E737–E745
doi: 10.1002/ccd.29506 pubmed: 33533544 pmcid: 9292646
Moriyama N, Dahlbacka S, Vähäsilta T et al (2019) The efficacy of the ultrasound-navigated MANTA deployment following transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv 12(24):2564–2566
doi: 10.1016/j.jcin.2019.09.018 pubmed: 31857032
Dahlbacka S, Vähäsilta T, Moriyama N et al (2020) Ultrasound-navigated manta deployment after removal of extracorporeal membrane oxygenation cannula. Ann Thorac Surg 110(4):e307–e309
doi: 10.1016/j.athoracsur.2020.01.064 pubmed: 32145194
Shah A, Ghoreishi M, Taylor BS et al (2020) Complete percutaneous decannulation from femoral venoarterial extracorporeal membrane oxygenation. JTCVS Tech 21(6):75–81
Biancari F, Romppanen H, Savontaus M et al (2018) MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation. Int J Cardiol 15(263):29–31
doi: 10.1016/j.ijcard.2018.04.065

Auteurs

Ernesto Mejia (E)

The Heart Center, Children's Hospital Colorado, University of Colorado, 13123 E 16th Ave, B100, Aurora, CO, 80045, USA.

Elaina Cummer (E)

The Heart Center, Children's Hospital Colorado, University of Colorado, 13123 E 16th Ave, B100, Aurora, CO, 80045, USA.

Gareth J Morgan (GJ)

The Heart Center, Children's Hospital Colorado, University of Colorado, 13123 E 16th Ave, B100, Aurora, CO, 80045, USA.

Shannon Buckvold (S)

The Heart Center, Children's Hospital Colorado, University of Colorado, 13123 E 16th Ave, B100, Aurora, CO, 80045, USA.

Max Mitchell (M)

The Heart Center, Children's Hospital Colorado, University of Colorado, 13123 E 16th Ave, B100, Aurora, CO, 80045, USA.

Ryan A Leahy (RA)

The Heart Center, Children's Hospital Colorado, University of Colorado, 13123 E 16th Ave, B100, Aurora, CO, 80045, USA.

Jenny E Zablah (JE)

The Heart Center, Children's Hospital Colorado, University of Colorado, 13123 E 16th Ave, B100, Aurora, CO, 80045, USA. Jenny.zablah@childrenscolorado.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH